Topics In Demand
Notification
New

No notification found.

BSI antimicrobial resistance certification launch event
BSI antimicrobial resistance certification launch event

26th Jun, 2023

03:00PM to 04:30PM IST

Virtual

+919582433506

33

1

Driving action and creating change against antimicrobial resistance

26 June Monday from 15:00 to 16:30 hrs (IST)

According to the World Health Organization, antimicrobial resistance (AMR) has been declared a top 10 global public health threat and is expected to get worse unless action is taken. It threatens to undermine the basis of modern medicine by rendering the antibiotics used to treat and prevent infections ineffective. Resistance can come from many sources – BSI is working with the pharmaceutical industry to focus on the evolution of responsible manufacturing of antibiotics.

Manufacturing waste from the production of antibiotics may contribute to the development of AMR in the environment unless emissions from waste streams are effectively controlled.

About the launch event

Date: 26 June 2023

BSI, in collaboration with the AMR Industry Alliance, will launch an industry antibiotic manufacturing certification scheme on 26 June 2023. In this event, you will learn how BSI will serve as an assessment body role that will enable antibiotic manufacturers to demonstrate that the environmental management, including waste water management and control requirements of the antibiotic manufacturing standard (which launched June 2022) have been satisfied.

This independent and impartial certification program is perfectly situated to serve as a mechanism for antibiotic manufacturers to demonstrate evolving best practice and compliance to the Antibiotic Manufacturing Standard. While government regulators have a role to play in promoting responsible manufacturing, the industry has shown its willingness to self-regulate by developing this manufacturing standard and independent certification scheme.

You will hear from clients on their experience with this certification, as they were the first organizations to take part in the assessment process. Companies including Centrient, Roche, Pfizer, Teva, Viatris, and Sandoz were participants in the pilot program and have helped provide technical expertise to shape the certification program.

  • Provide independent third-party assurance that your organization is minimizing the risk of waste emissions from manufacturing 
  • Prove that the industry can self-regulate the antimicrobial resistance topic through certification and external third-party independent assessments
  • Differentiate yourselves in healthcare systems tenders by showing your antibiotic products are independently certified by a trusted organization with a recognizable Mark of Trust

Who should attend?

  • Pharmaceutical manufacturers
  • Regulators
  • Government policy makers
  • Trade associations
  • Contract manufacturers
  • Hospital / healthcare systems sustainability procurement

BSI enables people and organizations to perform better. We share knowledge, innovation and best practice to make excellence a habit – all over the world, every day.

© Copyright nasscom. All Rights Reserved.